Equillium, Inc. (EQ)
Data as of , from SEC Form 4 filings.
No open-market insider trades (90d)Watch EQ
See up to 3 months of EQ. The 7-day demo opens the 1M and 3M ranges and puts EQ on your watchlist.
Start 7-day demoLatest EQ insider trades
About Equillium, Inc. (EQ)
Equillium, Inc. is an SEC registrant, filing under CIK 0001746466, classified as pharmaceutical preparations. We track it alongside the rest of the Health Care sector.
EQ Form 4 activity by transaction type, last 90 days
No Form 4 activity for EQ in the last 90 days.
EQ insider transactions (Form 4)
5726 Form 4 filings on record, the earliest from Oct 29, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Christine Zedelmayer - Officer | Option exercise | Common Stock | 14,584 | $0.79 | $11K | |
| Christine Zedelmayer - Officer | Open-market sale | Common Stock | 14,584 | $2.93 footnote F2 | $43K | |
| Christine Zedelmayer - Officer | Option exercise | Employee Stock Option (right to buy) | 14,584 | $0.00 | - | |
| ||||||
| Stephen Connelly - Officer | Open-market sale | Common Stock | 200,000 | $3.16 footnote F1 | $633K | |
| Stephen Connelly - Officer | Open-market sale | Common Stock | 30,975 | $2.94 footnote F2 | $91K | |
| ||||||
| Penny Tom - Officer | Option exercise | Common Stock | 65,000 | $0.79 | $51K | |
| Penny Tom - Officer | Open-market sale | Common Stock | 65,000 | $2.95 footnote F2 | $192K | |
| Penny Tom - Officer | Option exercise | Employee Stock Option (right to buy) | 65,000 | $0.00 | - | |
| ||||||
| Martha J. Demski | Grant or award | Director Stock Option (right to buy) | 70,000 | $0.00 | - | |
| Mark Pruzanski | Grant or award | Director Stock Option (right to buy) | 70,000 | $0.00 | - | |
| Daniel Bradbury - Officer | Grant or award | Director stock option (right to buy) | 70,000 | $0.00 | - | |
| Christine Zedelmayer - Officer | Option exercise | Common Stock | 9,821 | $0.77 | $8K | |
| Christine Zedelmayer - Officer | Option exercise | Common Stock | 7,292 | $0.73 | $5K | |
| Christine Zedelmayer - Officer | Option exercise | Common Stock | 48,512 | $0.77 | $37K | |
| Christine Zedelmayer - Officer | Option exercise | Common Stock | 14,583 | $0.79 | $11K | |
| Christine Zedelmayer - Officer | Option exercise | Common Stock | 15,625 | $0.79 | $12K | |
| Christine Zedelmayer - Officer | Open-market sale | Common Stock | 9,821 | $2.70 | $27K | |
| Christine Zedelmayer - Officer | Open-market sale | Common Stock | 55,604 | $2.70 | $150K | |
| Christine Zedelmayer - Officer | Open-market sale | Common Stock | 200 | $2.71 | $542 | |
| Christine Zedelmayer - Officer | Open-market sale | Common Stock | 30,208 | $2.98 footnote F2 | $90K | |
| Christine Zedelmayer - Officer | Option exercise | Employee Stock Option (right to buy) | 9,821 | $0.00 | - | |
| Christine Zedelmayer - Officer | Option exercise | Employee Stock Option (right to buy) | 7,292 | $0.00 | - | |
| Christine Zedelmayer - Officer | Option exercise | Employee Stock Option (right to buy) | 48,512 | $0.00 | - | |
| Christine Zedelmayer - Officer | Option exercise | Employee Stock Option (right to buy) | 14,583 | $0.00 | - | |
| Christine Zedelmayer - Officer | Option exercise | Employee Stock Option (right to buy) | 15,625 | $0.00 | - | |
| ||||||
| Charles Douglas McDermott | Grant or award | Director Stock Option (right to buy) | 70,000 | $0.00 | - | |
| Barbara Troupin | Grant or award | Director Stock Option (right to buy) | 70,000 | $0.00 | - | |
| Christine Zedelmayer - Officer | Option exercise | Common Stock | 120,312 | $0.79 | $94K | |
| Christine Zedelmayer - Officer | Open-market sale | Common Stock | 120,312 | $2.50 footnote F2 | $301K | |
| Christine Zedelmayer - Officer | Option exercise | Employee Stock Option (right to buy) | 120,312 | $0.00 | - | |
| ||||||
| Christine Zedelmayer - Officer | Option exercise | Common Stock | 109,375 | $0.79 | $86K | |
| Christine Zedelmayer - Officer | Open-market sale | Common Stock | 109,375 | $1.78 | $195K | |
| Christine Zedelmayer - Officer | Option exercise | Common Stock | 76,562 | $0.73 | $56K | |
| Christine Zedelmayer - Officer | Open-market sale | Common Stock | 76,562 | $1.74 | $133K | |
| Christine Zedelmayer - Officer | Option exercise | Common Stock | 109,375 | $0.79 | $86K | |
| Christine Zedelmayer - Officer | Option exercise | Common Stock | 76,562 | $0.73 | $56K | |
| Christine Zedelmayer - Officer | Open-market sale | Common Stock | 109,375 | $1.78 | $195K | |
| Christine Zedelmayer - Officer | Open-market sale | Common Stock | 76,562 | $1.74 | $133K | |
| Christine Zedelmayer - Officer | Option exercise | Employee Stock Option (right to buy) | 109,375 | $0.00 | - | |
| Christine Zedelmayer - Officer | Option exercise | Employee Stock Option (right to buy) | 76,562 | $0.00 | - | |
| Stephen Connelly - Officer | Grant or award | Employee Stock Option (right to buy) | 1,150,000 | $0.00 | - | |
| Christine Zedelmayer - Officer | Grant or award | Employee Stock Option (right to buy) | 500,000 | $0.00 | - | |
| Bruce D. Steel - Officer | Grant or award | Employee Stock Option (right to buy) | 1,750,000 | $0.00 | - | |
| Penny Tom - Officer | Open-market sale | Common Stock | 6,533 | $1.29 | $8K | |
| Penny Tom - Officer | Grant or award | Employee Stock Option (right to buy) | 450,000 | $0.00 | - | |
| Christine Zedelmayer - Officer | Open-market sale | Common Stock | 100 | $0.98 | $98 | |
| Christine Zedelmayer - Officer | Open-market sale | Common Stock | 7,998 | $0.95 | $8K | |
| Stephen Connelly - Officer | Grant or award | Employee Stock Option (right to buy) | 1,025,000 | $0.00 | - | |
| Penny Tom - Officer | Grant or award | Employee Stock Option (right to buy) | 525,000 | $0.00 | - | |
| Christine Zedelmayer - Officer | Grant or award | Employee Stock Option (right to buy) | 725,000 | $0.00 | - | |
| Bruce D. Steel - Officer | Grant or award | Employee Stock Option (right to buy) | 1,695,000 | $0.00 | - | |
| Martha J. Demski | Grant or award | Director Stock Option (right to buy) | 20,000 | $0.00 | - | |
| Peter Colabuono | Grant or award | Director Stock Option (right to buy) | 40,000 | $0.00 | - | |
| Jason A. Keyes - Officer | Open-market sale | Common Stock | 10,000 | $0.70 | $7K | |
| Christine Zedelmayer - Officer | Open-market sale | Common Stock | 15,000 | $1.25 | $19K | |
| Penny Tom - Officer | Open-market sale | Common Stock | 683 | $1.25 | $854 | |
| Penny Tom - Officer | Open-market sale | Common Stock | 2,835 | $1.25 | $4K | |
Item 8.01
Item 2.02, 9.01
Item 5.07, 9.01
Item 2.02, 9.01
Recent EQ Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| - | - | - | - | View on EDGAR | |
| - | - | - | - |
EQ insider trading FAQ
What is the latest insider trade for EQ?
Equillium, Inc. (EQ) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-06-05. The full record for EQ runs to 26 Form 4 filings, the earliest from 2024-10-29. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying EQ stock?
No insider purchases of EQ were filed in the last 90 days.
How many insiders are selling EQ stock?
No insider sales of EQ were filed in the last 90 days. 20 sales are on record for this company.
Where can I see EQ SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects EQ Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Christine Zedelmayer view on EDGAR
- - Stephen Connelly view on EDGAR
- - Penny Tom view on EDGAR
- - Martha J. Demski view on EDGAR
- - Mark Pruzanski view on EDGAR
- - Daniel Bradbury view on EDGAR
- - Christine Zedelmayer view on EDGAR
- - Charles Douglas McDermott view on EDGAR
- - Barbara Troupin view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where EQ's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow EQ with a 7-day demo
- EQ on your watchlist
- Every EQ Form 4 filing on record
- Up to 3 months of EQ price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
